Hugging Face's logo

Spaces:
Eric2020188
/
adhderinspace
Running

App Files Community
Eric2020188 commited on
Commit
f6a09e4
·
verified ·
1 Parent(s): 0461e74

should an ADHD have SNRIs all life long - Initial Deployment

Browse files
Files changed (2) hide show
  1. README.md +7 -5
  2. index.html +435 -19
README.md CHANGED
@@ -1,10 +1,12 @@
1
  ---
2
- title: Adhderinspace
3
- emoji: 🏆
4
- colorFrom: purple
5
- colorTo: red
6
  sdk: static
7
  pinned: false
 
 
8
  ---
9
 
10
- Check out the configuration reference at https://huggingface.co/docs/hub/spaces-config-reference
 
1
  ---
2
+ title: adhderinspace
3
+ emoji: 🐳
4
+ colorFrom: green
5
+ colorTo: green
6
  sdk: static
7
  pinned: false
8
+ tags:
9
+ - deepsite
10
  ---
11
 
12
+ Check out the configuration reference at https://huggingface.co/docs/hub/spaces-config-reference
index.html CHANGED
@@ -1,19 +1,435 @@
1
- <!doctype html>
2
- <html>
3
- <head>
4
- <meta charset="utf-8" />
5
- <meta name="viewport" content="width=device-width" />
6
- <title>My static Space</title>
7
- <link rel="stylesheet" href="style.css" />
8
- </head>
9
- <body>
10
- <div class="card">
11
- <h1>Welcome to your static Space!</h1>
12
- <p>You can modify this app directly by editing <i>index.html</i> in the Files and versions tab.</p>
13
- <p>
14
- Also don't forget to check the
15
- <a href="https://huggingface.co/docs/hub/spaces" target="_blank">Spaces documentation</a>.
16
- </p>
17
- </div>
18
- </body>
19
- </html>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <!DOCTYPE html>
2
+ <html lang="en">
3
+ <head>
4
+ <meta charset="UTF-8">
5
+ <meta name="viewport" content="width=device-width, initial-scale=1.0">
6
+ <title>ADHD & SNRIs: Long-Term Treatment Considerations</title>
7
+ <script src="https://cdn.tailwindcss.com"></script>
8
+ <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
9
+ <style>
10
+ .gradient-bg {
11
+ background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
12
+ }
13
+ .card-hover:hover {
14
+ transform: translateY(-5px);
15
+ box-shadow: 0 10px 20px rgba(0,0,0,0.1);
16
+ }
17
+ .pulse {
18
+ animation: pulse 2s infinite;
19
+ }
20
+ @keyframes pulse {
21
+ 0% { transform: scale(1); }
22
+ 50% { transform: scale(1.05); }
23
+ 100% { transform: scale(1); }
24
+ }
25
+ </style>
26
+ </head>
27
+ <body class="gradient-bg min-h-screen font-sans">
28
+ <header class="bg-indigo-900 text-white shadow-lg">
29
+ <div class="container mx-auto px-4 py-6">
30
+ <div class="flex justify-between items-center">
31
+ <div class="flex items-center space-x-3">
32
+ <i class="fas fa-brain text-3xl text-indigo-300"></i>
33
+ <h1 class="text-2xl md:text-3xl font-bold">ADHD & SNRIs</h1>
34
+ </div>
35
+ <button class="md:hidden text-xl" id="menu-toggle">
36
+ <i class="fas fa-bars"></i>
37
+ </button>
38
+ <nav class="hidden md:flex space-x-6">
39
+ <a href="#overview" class="hover:text-indigo-200 transition">Overview</a>
40
+ <a href="#treatment" class="hover:text-indigo-200 transition">Treatment</a>
41
+ <a href="#alternatives" class="hover:text-indigo-200 transition">Alternatives</a>
42
+ <a href="#faq" class="hover:text-indigo-200 transition">FAQ</a>
43
+ </nav>
44
+ </div>
45
+ </div>
46
+ <div class="md:hidden hidden bg-indigo-800 px-4 py-2" id="mobile-menu">
47
+ <div class="flex flex-col space-y-3">
48
+ <a href="#overview" class="hover:text-indigo-200 transition">Overview</a>
49
+ <a href="#treatment" class="hover:text-indigo-200 transition">Treatment</a>
50
+ <a href="#alternatives" class="hover:text-indigo-200 transition">Alternatives</a>
51
+ <a href="#faq" class="hover:text-indigo-200 transition">FAQ</a>
52
+ </div>
53
+ </div>
54
+ </header>
55
+
56
+ <main class="container mx-auto px-4 py-8">
57
+ <section id="hero" class="mb-16">
58
+ <div class="bg-white rounded-xl shadow-md overflow-hidden md:flex">
59
+ <div class="md:w-1/2 p-8 md:p-12 flex flex-col justify-center">
60
+ <h2 class="text-3xl md:text-4xl font-bold text-gray-800 mb-4">Understanding ADHD & SNRIs</h2>
61
+ <p class="text-gray-600 mb-6">Exploring the long-term use of serotonin-norepinephrine reuptake inhibitors (SNRIs) for ADHD management and what current research suggests.</p>
62
+ <div class="flex space-x-4">
63
+ <a href="#treatment" class="bg-indigo-600 hover:bg-indigo-700 text-white px-6 py-3 rounded-lg font-medium transition duration-300">Learn More</a>
64
+ <a href="#faq" class="border border-indigo-600 text-indigo-600 hover:bg-indigo-50 px-6 py-3 rounded-lg font-medium transition duration-300">FAQs</a>
65
+ </div>
66
+ </div>
67
+ <div class="md:w-1/2">
68
+ <img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?ixlib=rb-4.0.3&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&w=1470&q=80" alt="Brain and medication" class="w-full h-full object-cover">
69
+ </div>
70
+ </div>
71
+ </section>
72
+
73
+ <section id="overview" class="mb-16">
74
+ <div class="text-center mb-12">
75
+ <h2 class="text-3xl font-bold text-gray-800 mb-4">ADHD and SNRIs: Key Considerations</h2>
76
+ <div class="w-20 h-1 bg-indigo-600 mx-auto mb-6"></div>
77
+ <p class="text-gray-600 max-w-3xl mx-auto">Attention Deficit Hyperactivity Disorder (ADHD) is typically treated with stimulant medications, but SNRIs are sometimes considered, especially when there are co-occurring conditions.</p>
78
+ </div>
79
+
80
+ <div class="grid md:grid-cols-3 gap-8">
81
+ <div class="bg-white p-8 rounded-xl shadow-md card-hover transition duration-300">
82
+ <div class="text-indigo-600 mb-4">
83
+ <i class="fas fa-question-circle text-4xl"></i>
84
+ </div>
85
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Are SNRIs First-Line?</h3>
86
+ <p class="text-gray-600">SNRIs are not typically first-line treatments for ADHD. Stimulant medications like methylphenidate and amphetamines are usually more effective for core ADHD symptoms.</p>
87
+ </div>
88
+ <div class="bg-white p-8 rounded-xl shadow-md card-hover transition duration-300">
89
+ <div class="text-indigo-600 mb-4">
90
+ <i class="fas fa-user-md text-4xl"></i>
91
+ </div>
92
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">When Are They Used?</h3>
93
+ <p class="text-gray-600">SNRIs may be considered when ADHD co-occurs with depression or anxiety, or when patients don't respond well to stimulants or can't tolerate their side effects.</p>
94
+ </div>
95
+ <div class="bg-white p-8 rounded-xl shadow-md card-hover transition duration-300">
96
+ <div class="text-indigo-600 mb-4">
97
+ <i class="fas fa-calendar-check text-4xl"></i>
98
+ </div>
99
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Long-Term Use?</h3>
100
+ <p class="text-gray-600">There's limited research on lifelong SNRI use for ADHD. Treatment should be regularly reassessed based on symptom control, side effects, and quality of life.</p>
101
+ </div>
102
+ </div>
103
+ </section>
104
+
105
+ <section id="treatment" class="mb-16 bg-white rounded-xl shadow-md overflow-hidden">
106
+ <div class="md:flex">
107
+ <div class="md:w-1/2 p-8 md:p-12">
108
+ <h2 class="text-3xl font-bold text-gray-800 mb-6">SNRIs for ADHD Treatment</h2>
109
+ <div class="space-y-6">
110
+ <div class="flex items-start">
111
+ <div class="flex-shrink-0 bg-indigo-100 rounded-full p-2 mr-4">
112
+ <i class="fas fa-pills text-indigo-600"></i>
113
+ </div>
114
+ <div>
115
+ <h3 class="text-xl font-semibold text-gray-800 mb-2">Common SNRIs Used</h3>
116
+ <p class="text-gray-600">Venlafaxine (Effexor) and duloxetine (Cymbalta) are the most studied SNRIs for ADHD, though they're not FDA-approved for this specific use.</p>
117
+ </div>
118
+ </div>
119
+ <div class="flex items-start">
120
+ <div class="flex-shrink-0 bg-indigo-100 rounded-full p-2 mr-4">
121
+ <i class="fas fa-chart-line text-indigo-600"></i>
122
+ </div>
123
+ <div>
124
+ <h3 class="text-xl font-semibold text-gray-800 mb-2">Effectiveness</h3>
125
+ <p class="text-gray-600">Research shows SNRIs may help with emotional regulation and some cognitive symptoms, but are generally less effective than stimulants for core ADHD symptoms.</p>
126
+ </div>
127
+ </div>
128
+ <div class="flex items-start">
129
+ <div class="flex-shrink-0 bg-indigo-100 rounded-full p-2 mr-4">
130
+ <i class="fas fa-clock text-indigo-600"></i>
131
+ </div>
132
+ <div>
133
+ <h3 class="text-xl font-semibold text-gray-800 mb-2">Duration of Treatment</h3>
134
+ <p class="text-gray-600">There's no definitive answer about lifelong use. Treatment should be individualized, with regular evaluations of benefits versus side effects.</p>
135
+ </div>
136
+ </div>
137
+ </div>
138
+ </div>
139
+ <div class="md:w-1/2 bg-indigo-50 flex items-center justify-center p-8">
140
+ <div class="max-w-md">
141
+ <div class="bg-white p-6 rounded-lg shadow-md mb-6">
142
+ <h3 class="text-xl font-semibold text-gray-800 mb-4">Potential Benefits</h3>
143
+ <ul class="space-y-3 text-gray-600">
144
+ <li class="flex items-start">
145
+ <i class="fas fa-check-circle text-green-500 mt-1 mr-2"></i>
146
+ <span>May help with co-occurring depression/anxiety</span>
147
+ </li>
148
+ <li class="flex items-start">
149
+ <i class="fas fa-check-circle text-green-500 mt-1 mr-2"></i>
150
+ <span>Lower abuse potential than stimulants</span>
151
+ </li>
152
+ <li class="flex items-start">
153
+ <i class="fas fa-check-circle text-green-500 mt-1 mr-2"></i>
154
+ <span>May improve emotional dysregulation</span>
155
+ </li>
156
+ </ul>
157
+ </div>
158
+ <div class="bg-white p-6 rounded-lg shadow-md">
159
+ <h3 class="text-xl font-semibold text-gray-800 mb-4">Potential Drawbacks</h3>
160
+ <ul class="space-y-3 text-gray-600">
161
+ <li class="flex items-start">
162
+ <i class="fas fa-exclamation-circle text-red-500 mt-1 mr-2"></i>
163
+ <span>Less effective for core ADHD symptoms</span>
164
+ </li>
165
+ <li class="flex items-start">
166
+ <i class="fas fa-exclamation-circle text-red-500 mt-1 mr-2"></i>
167
+ <span>Possible side effects (nausea, insomnia, etc.)</span>
168
+ </li>
169
+ <li class="flex items-start">
170
+ <i class="fas fa-exclamation-circle text-red-500 mt-1 mr-2"></i>
171
+ <span>Withdrawal symptoms if stopped abruptly</span>
172
+ </li>
173
+ </ul>
174
+ </div>
175
+ </div>
176
+ </div>
177
+ </div>
178
+ </section>
179
+
180
+ <section id="alternatives" class="mb-16">
181
+ <div class="text-center mb-12">
182
+ <h2 class="text-3xl font-bold text-gray-800 mb-4">Alternative Treatment Options</h2>
183
+ <div class="w-20 h-1 bg-indigo-600 mx-auto mb-6"></div>
184
+ <p class="text-gray-600 max-w-3xl mx-auto">For individuals with ADHD who cannot or choose not to use SNRIs long-term, several alternative treatment approaches exist.</p>
185
+ </div>
186
+
187
+ <div class="grid md:grid-cols-2 lg:grid-cols-4 gap-6">
188
+ <div class="bg-white rounded-xl shadow-md overflow-hidden card-hover transition duration-300">
189
+ <div class="h-40 bg-indigo-100 flex items-center justify-center">
190
+ <i class="fas fa-bolt text-5xl text-indigo-600"></i>
191
+ </div>
192
+ <div class="p-6">
193
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Stimulant Medications</h3>
194
+ <p class="text-gray-600">Methylphenidate and amphetamine-based medications are first-line treatments with strong evidence for ADHD symptom reduction.</p>
195
+ </div>
196
+ </div>
197
+ <div class="bg-white rounded-xl shadow-md overflow-hidden card-hover transition duration-300">
198
+ <div class="h-40 bg-indigo-100 flex items-center justify-center">
199
+ <i class="fas fa-leaf text-5xl text-indigo-600"></i>
200
+ </div>
201
+ <div class="p-6">
202
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Non-Stimulant Medications</h3>
203
+ <p class="text-gray-600">Atomoxetine (Strattera) and guanfacine (Intuniv) are FDA-approved non-stimulant options with different mechanisms than SNRIs.</p>
204
+ </div>
205
+ </div>
206
+ <div class="bg-white rounded-xl shadow-md overflow-hidden card-hover transition duration-300">
207
+ <div class="h-40 bg-indigo-100 flex items-center justify-center">
208
+ <i class="fas fa-brain text-5xl text-indigo-600"></i>
209
+ </div>
210
+ <div class="p-6">
211
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Behavioral Therapies</h3>
212
+ <p class="text-gray-600">Cognitive Behavioral Therapy (CBT) and ADHD coaching can help develop coping strategies and improve executive functioning.</p>
213
+ </div>
214
+ </div>
215
+ <div class="bg-white rounded-xl shadow-md overflow-hidden card-hover transition duration-300">
216
+ <div class="h-40 bg-indigo-100 flex items-center justify-center">
217
+ <i class="fas fa-heartbeat text-5xl text-indigo-600"></i>
218
+ </div>
219
+ <div class="p-6">
220
+ <h3 class="text-xl font-semibold mb-3 text-gray-800">Lifestyle Approaches</h3>
221
+ <p class="text-gray-600">Exercise, sleep hygiene, nutrition, and mindfulness practices can complement other treatments for ADHD management.</p>
222
+ </div>
223
+ </div>
224
+ </div>
225
+ </section>
226
+
227
+ <section id="faq" class="mb-16 bg-indigo-50 rounded-xl p-8">
228
+ <div class="text-center mb-12">
229
+ <h2 class="text-3xl font-bold text-gray-800 mb-4">Frequently Asked Questions</h2>
230
+ <div class="w-20 h-1 bg-indigo-600 mx-auto mb-6"></div>
231
+ </div>
232
+
233
+ <div class="max-w-3xl mx-auto space-y-6">
234
+ <div class="bg-white p-6 rounded-lg shadow-md">
235
+ <button class="flex justify-between items-center w-full text-left focus:outline-none" onclick="toggleFAQ(1)">
236
+ <h3 class="text-xl font-semibold text-gray-800">Should someone with ADHD take SNRIs for life?</h3>
237
+ <i class="fas fa-chevron-down text-indigo-600 transition-transform duration-300" id="faq-icon-1"></i>
238
+ </button>
239
+ <div class="mt-4 text-gray-600 hidden" id="faq-content-1">
240
+ <p>There's no one-size-fits-all answer to this question. The decision to use SNRIs long-term for ADHD should be made on an individual basis in consultation with a healthcare provider. Considerations include:</p>
241
+ <ul class="mt-3 space-y-2 pl-5 list-disc">
242
+ <li>How well the medication controls symptoms</li>
243
+ <li>Presence of side effects</li>
244
+ <li>Co-occurring conditions that may benefit from SNRIs</li>
245
+ <li>Patient preference and quality of life</li>
246
+ <li>Availability and effectiveness of alternative treatments</li>
247
+ </ul>
248
+ <p class="mt-3">Regular reassessment (at least annually) is recommended to determine if continued treatment is beneficial.</p>
249
+ </div>
250
+ </div>
251
+
252
+ <div class="bg-white p-6 rounded-lg shadow-md">
253
+ <button class="flex justify-between items-center w-full text-left focus:outline-none" onclick="toggleFAQ(2)">
254
+ <h3 class="text-xl font-semibold text-gray-800">How do SNRIs compare to stimulants for ADHD treatment?</h3>
255
+ <i class="fas fa-chevron-down text-indigo-600 transition-transform duration-300" id="faq-icon-2"></i>
256
+ </button>
257
+ <div class="mt-4 text-gray-600 hidden" id="faq-content-2">
258
+ <p>Stimulant medications (like methylphenidate and amphetamines) are generally more effective than SNRIs for treating core ADHD symptoms of inattention, hyperactivity, and impulsivity. Key differences:</p>
259
+ <div class="mt-3 grid md:grid-cols-2 gap-4">
260
+ <div>
261
+ <h4 class="font-medium text-gray-800">Stimulants</h4>
262
+ <ul class="mt-2 space-y-2 pl-5 list-disc">
263
+ <li>70-80% response rate for ADHD symptoms</li>
264
+ <li>Work quickly (within hours)</li>
265
+ <li>Directly increase dopamine and norepinephrine</li>
266
+ <li>More side effects like appetite suppression</li>
267
+ </ul>
268
+ </div>
269
+ <div>
270
+ <h4 class="font-medium text-gray-800">SNRIs</h4>
271
+ <ul class="mt-2 space-y-2 pl-5 list-disc">
272
+ <li>30-50% response rate for ADHD symptoms</li>
273
+ <li>Take weeks to show full effect</li>
274
+ <li>Primarily affect serotonin and norepinephrine</li>
275
+ <li>May help with co-occurring mood disorders</li>
276
+ </ul>
277
+ </div>
278
+ </div>
279
+ </div>
280
+ </div>
281
+
282
+ <div class="bg-white p-6 rounded-lg shadow-md">
283
+ <button class="flex justify-between items-center w-full text-left focus:outline-none" onclick="toggleFAQ(3)">
284
+ <h3 class="text-xl font-semibold text-gray-800">What are the risks of long-term SNRI use?</h3>
285
+ <i class="fas fa-chevron-down text-indigo-600 transition-transform duration-300" id="faq-icon-3"></i>
286
+ </button>
287
+ <div class="mt-4 text-gray-600 hidden" id="faq-content-3">
288
+ <p>Potential risks of long-term SNRI use include:</p>
289
+ <ul class="mt-3 space-y-2 pl-5 list-disc">
290
+ <li><strong>Tolerance:</strong> Some patients may need dose increases over time</li>
291
+ <li><strong>Withdrawal symptoms:</strong> Discontinuation syndrome if stopped abruptly (dizziness, nausea, "brain zaps")</li>
292
+ <li><strong>Emotional blunting:</strong> Some report reduced ability to experience emotions</li>
293
+ <li><strong>Sexual side effects:</strong> May persist long-term in some individuals</li>
294
+ <li><strong>Unknown long-term effects:</strong> Limited data on decades of continuous use</li>
295
+ <li><strong>Interactions:</strong> Potential for drug interactions may increase with age</li>
296
+ </ul>
297
+ <p class="mt-3">However, for some individuals, the benefits may outweigh these risks when properly managed.</p>
298
+ </div>
299
+ </div>
300
+
301
+ <div class="bg-white p-6 rounded-lg shadow-md">
302
+ <button class="flex justify-between items-center w-full text-left focus:outline-none" onclick="toggleFAQ(4)">
303
+ <h3 class="text-xl font-semibold text-gray-800">Are there natural alternatives to SNRIs for ADHD?</h3>
304
+ <i class="fas fa-chevron-down text-indigo-600 transition-transform duration-300" id="faq-icon-4"></i>
305
+ </button>
306
+ <div class="mt-4 text-gray-600 hidden" id="faq-content-4">
307
+ <p>While natural alternatives typically aren't as potent as medications, some options with varying levels of evidence include:</p>
308
+ <div class="mt-3 grid md:grid-cols-2 gap-4">
309
+ <div>
310
+ <h4 class="font-medium text-gray-800">Supplements</h4>
311
+ <ul class="mt-2 space-y-2 pl-5 list-disc">
312
+ <li>Omega-3 fatty acids (especially EPA)</li>
313
+ <li>Zinc, iron (if deficient)</li>
314
+ <li>Magnesium</li>
315
+ <li>Pycnogenol (pine bark extract)</li>
316
+ </ul>
317
+ </div>
318
+ <div>
319
+ <h4 class="font-medium text-gray-800">Lifestyle Approaches</h4>
320
+ <ul class="mt-2 space-y-2 pl-5 list-disc">
321
+ <li>Regular aerobic exercise</li>
322
+ <li>Mindfulness meditation</li>
323
+ <li>Behavioral therapy techniques</li>
324
+ <li>Sleep optimization</li>
325
+ </ul>
326
+ </div>
327
+ </div>
328
+ <p class="mt-3">Note that evidence for these alternatives is generally weaker than for medications, and they may work best as complements to other treatments.</p>
329
+ </div>
330
+ </div>
331
+ </div>
332
+ </section>
333
+
334
+ <section class="bg-indigo-900 text-white rounded-xl p-8 md:p-12 text-center pulse">
335
+ <h2 class="text-2xl md:text-3xl font-bold mb-6">Important Reminder</h2>
336
+ <p class="text-lg md:text-xl mb-8 max-w-3xl mx-auto">ADHD treatment should always be personalized. Decisions about long-term medication use should be made in collaboration with a qualified healthcare provider who understands your unique situation.</p>
337
+ <div class="flex flex-col sm:flex-row justify-center space-y-4 sm:space-y-0 sm:space-x-6">
338
+ <a href="#" class="bg-white hover:bg-gray-100 text-indigo-900 px-8 py-4 rounded-lg font-bold transition duration-300 inline-block">Find a Specialist</a>
339
+ <a href="#" class="border-2 border-white hover:bg-indigo-800 px-8 py-4 rounded-lg font-bold transition duration-300 inline-block">Learn More About ADHD</a>
340
+ </div>
341
+ </section>
342
+ </main>
343
+
344
+ <footer class="bg-gray-800 text-white py-12">
345
+ <div class="container mx-auto px-4">
346
+ <div class="grid md:grid-cols-4 gap-8">
347
+ <div>
348
+ <h3 class="text-xl font-semibold mb-4">ADHD Resources</h3>
349
+ <ul class="space-y-2">
350
+ <li><a href="#" class="hover:text-indigo-300 transition">CHADD</a></li>
351
+ <li><a href="#" class="hover:text-indigo-300 transition">ADDA</a></li>
352
+ <li><a href="#" class="hover:text-indigo-300 transition">Understood</a></li>
353
+ </ul>
354
+ </div>
355
+ <div>
356
+ <h3 class="text-xl font-semibold mb-4">Medication Info</h3>
357
+ <ul class="space-y-2">
358
+ <li><a href="#" class="hover:text-indigo-300 transition">FDA Information</a></li>
359
+ <li><a href="#" class="hover:text-indigo-300 transition">Medication Guides</a></li>
360
+ <li><a href="#" class="hover:text-indigo-300 transition">Research Studies</a></li>
361
+ </ul>
362
+ </div>
363
+ <div>
364
+ <h3 class="text-xl font-semibold mb-4">Support</h3>
365
+ <ul class="space-y-2">
366
+ <li><a href="#" class="hover:text-indigo-300 transition">Find a Therapist</a></li>
367
+ <li><a href="#" class="hover:text-indigo-300 transition">Support Groups</a></li>
368
+ <li><a href="#" class="hover:text-indigo-300 transition">Crisis Resources</a></li>
369
+ </ul>
370
+ </div>
371
+ <div>
372
+ <h3 class="text-xl font-semibold mb-4">Connect</h3>
373
+ <div class="flex space-x-4 mb-4">
374
+ <a href="#" class="hover:text-indigo-300 transition"><i class="fab fa-facebook-f text-xl"></i></a>
375
+ <a href="#" class="hover:text-indigo-300 transition"><i class="fab fa-twitter text-xl"></i></a>
376
+ <a href="#" class="hover:text-indigo-300 transition"><i class="fab fa-instagram text-xl"></i></a>
377
+ <a href="#" class="hover:text-indigo-300 transition"><i class="fab fa-youtube text-xl"></i></a>
378
+ </div>
379
+ <p class="text-gray-400">Subscribe to our newsletter</p>
380
+ <div class="mt-2 flex">
381
+ <input type="email" placeholder="Your email" class="px-4 py-2 rounded-l-lg text-gray-800 w-full">
382
+ <button class="bg-indigo-600 hover:bg-indigo-700 px-4 py-2 rounded-r-lg"><i class="fas fa-paper-plane"></i></button>
383
+ </div>
384
+ </div>
385
+ </div>
386
+ <div class="border-t border-gray-700 mt-12 pt-8 text-center text-gray-400">
387
+ <p>This information is for educational purposes only and not a substitute for professional medical advice.</p>
388
+ <p class="mt-2">© 2023 ADHD Treatment Resources. All rights reserved.</p>
389
+ </div>
390
+ </div>
391
+ </footer>
392
+
393
+ <script>
394
+ // Mobile menu toggle
395
+ document.getElementById('menu-toggle').addEventListener('click', function() {
396
+ const menu = document.getElementById('mobile-menu');
397
+ menu.classList.toggle('hidden');
398
+ });
399
+
400
+ // FAQ toggle functionality
401
+ function toggleFAQ(num) {
402
+ const content = document.getElementById(`faq-content-${num}`);
403
+ const icon = document.getElementById(`faq-icon-${num}`);
404
+
405
+ content.classList.toggle('hidden');
406
+ icon.classList.toggle('transform');
407
+ icon.classList.toggle('rotate-180');
408
+ }
409
+
410
+ // Smooth scrolling for anchor links
411
+ document.querySelectorAll('a[href^="#"]').forEach(anchor => {
412
+ anchor.addEventListener('click', function (e) {
413
+ e.preventDefault();
414
+
415
+ const targetId = this.getAttribute('href');
416
+ if (targetId === '#') return;
417
+
418
+ const targetElement = document.querySelector(targetId);
419
+ if (targetElement) {
420
+ window.scrollTo({
421
+ top: targetElement.offsetTop - 80,
422
+ behavior: 'smooth'
423
+ });
424
+
425
+ // Close mobile menu if open
426
+ const mobileMenu = document.getElementById('mobile-menu');
427
+ if (!mobileMenu.classList.contains('hidden')) {
428
+ mobileMenu.classList.add('hidden');
429
+ }
430
+ }
431
+ });
432
+ });
433
+ </script>
434
+ <p style="border-radius: 8px; text-align: center; font-size: 12px; color: #fff; margin-top: 16px;position: fixed; left: 8px; bottom: 8px; z-index: 10; background: rgba(0, 0, 0, 0.8); padding: 4px 8px;">Made with <img src="https://enzostvs-deepsite.hf.space/logo.svg" alt="DeepSite Logo" style="width: 16px; height: 16px; vertical-align: middle;display:inline-block;margin-right:3px;filter:brightness(0) invert(1);"><a href="https://enzostvs-deepsite.hf.space" style="color: #fff;text-decoration: underline;" target="_blank" >DeepSite</a> - 🧬 <a href="https://enzostvs-deepsite.hf.space?remix=Eric2020188/adhderinspace" style="color: #fff;text-decoration: underline;" target="_blank" >Remix</a></p></body>
435
+ </html>